Other OTC Pharmaceuticals (Pharmacies) - Uganda

  • Uganda
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$3.85m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.28%, resulting in a market volume of US$4.31m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.08 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Uganda is experiencing significant growth and development. Customer preferences in the market are shifting towards self-medication and over-the-counter (OTC) pharmaceuticals. This is driven by several factors, including the increasing prevalence of minor ailments and the convenience of purchasing medications without a prescription. Consumers are becoming more knowledgeable about their health and are seeking accessible and affordable solutions to their healthcare needs. Trends in the market indicate a growing demand for OTC pharmaceuticals in Uganda. This can be attributed to the expanding middle class, rising disposable incomes, and improved healthcare infrastructure. As more people have access to healthcare services, the demand for OTC medications is expected to continue increasing. Additionally, the COVID-19 pandemic has further accelerated the demand for OTC pharmaceuticals, as people seek to protect themselves and manage mild symptoms at home. Local special circumstances in Uganda also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a high burden of communicable diseases, such as malaria and HIV/AIDS, which require continuous access to medications. Pharmacies play a crucial role in providing essential medications to the population, especially in rural areas where access to healthcare facilities may be limited. The government has also implemented policies to promote the availability and affordability of OTC medications, further driving market growth. Underlying macroeconomic factors are also driving the development of the Other OTC Pharmaceuticals (Pharmacies) market in Uganda. The country has experienced sustained economic growth in recent years, leading to an expansion of the middle class and increased consumer spending power. This has translated into higher demand for healthcare products and services, including OTC pharmaceuticals. Additionally, the government has implemented policies to improve healthcare access and affordability, which has created a favorable environment for the growth of the OTC pharmaceutical market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Uganda is experiencing significant growth and development. Customer preferences are shifting towards self-medication and OTC pharmaceuticals, driven by the increasing prevalence of minor ailments and the convenience of purchasing medications without a prescription. Trends in the market indicate a growing demand for OTC pharmaceuticals, fueled by the expanding middle class, rising disposable incomes, and improved healthcare infrastructure. Local special circumstances, such as the high burden of communicable diseases and government policies promoting accessibility and affordability, further contribute to market growth. Underlying macroeconomic factors, including sustained economic growth and government healthcare initiatives, are also driving the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)